[ad_1]
Authored by: Zhang Yunwei (Mark) , Yang Fan , Li Lingbi and Cui Yangyang
Under the Chinese medical device regulatory regime, as filing/registration is compulsory prior to marketization, the legality of use of unregistered in vitro diagnostics reagents (“IVD”) in laboratory-developed testing (“LDT”) has been in a grey area for a long time.
[ad_2]
Source link
